Goldman Sachs
CELG

Goldman Sachs’s Celgene Corp CELG Stock Holding History

Goldman Sachs’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-715,700
Closed -$71.1M – 5594
2019
Q3 		$71.1M Sell
715,700
-121,200
-14% -$11.5M 0.02% 869
2019
Q2 		$77.4M Sell
836,900
-618,800
-43% -$58.8M 0.02% 839
2019
Q1 		$137M Buy
1,455,700
+891,500
+158% +$78M 0.04% 501
2018
Q4 		$36.2M Buy
564,200
+6,800
+1% +$502K 0.01% 1335
2018
Q3 		$49.9M Sell
557,400
-32,200
-5% -$2.85M 0.01% 1230
2018
Q2 		$46.8M Buy
589,600
+11,100
+2% +$922K 0.01% 1254
2018
Q1 		$51.6M Buy
578,500
+29,400
+5% +$2.82M 0.01% 1176
2017
Q4 		$57.3M Buy
549,100
+194,100
+55% +$21.9M 0.01% 1188
2017
Q3 		$51.8M Buy
355,000
+79,200
+29% +$10.8M 0.01% 1259
2017
Q2 		$35.8M Sell
275,800
-66,700
-19% -$8.17M 0.01% 1492
2017
Q1 		$42.6M Sell
342,500
-447,700
-57% -$53.6M 0.01% 1331
2016
Q4 		$91.5M Buy
790,200
+74,800
+10% +$8.33M 0.03% 831
2016
Q3 		$74.8M Sell
715,400
-31,000
-4% -$3.36M 0.02% 907
2016
Q2 		$73.6M Buy
746,400
+524,700
+237% +$54.3M 0.02% 849
2016
Q1 		$22.2M Sell
221,700
-242,000
-52% -$24.9M 0.01% 1651
2015
Q4 		$55.5M Sell
463,700
-197,200
-30% -$22.8M 0.02% 1045
2015
Q3 		$71.5M Buy
660,900
+87,600
+15% +$10.9M 0.02% 823
2015
Q2 		$66.4M Sell
573,300
-59,500
-9% -$6.8M 0.02% 911
2015
Q1 		$72.9M Sell
632,800
-24,600
-4% -$2.94M 0.02% 822
2014
Q4 		$73.5M Buy
657,400
+24,200
+4% +$2.55M 0.02% 850
2014
Q3 		$60M Sell
633,200
-19,400
-3% -$1.75M 0.02% 938
2014
Q2 		$56M Sell
652,600
-54,200
-8% -$4.12M 0.02% 1010
2014
Q1 		$49.3M Buy
706,800
+73,800
+12% +$5.84M 0.02% 1066
2013
Q4 		$53.5M Buy
633,000
+40,200
+7% +$3.18M 0.02% 995
2013
Q3 		$45.7M Buy
592,800
+120,000
+25% +$8.41M 0.02% 1024
2013
Q2 		$27.7M Buy
+472,800
New +$28.5M 0.01% 1291

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Goldman Sachs's CELG Position: Q4 2019 in Review

Goldman Sachs sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,449,861 shares — an estimated $740M sold.

Goldman Sachs first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $892M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Goldman Sachs reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Goldman Sachs sold 7,449,861 Celgene Corp shares in Q4 2019, an estimated $740M.
  • Goldman Sachs first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Goldman Sachs's Celgene Corp position peaked at $892M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.